Dipeptide diaminobutyroyl benzylamide diacetate

Name: Dipeptide diaminobutyroyl benzylamide diacetate
Brand: MedChemExpress
SKU: HY-P0102
Rating: 4.5 (0 reviews)

Art. -Nr.: HY-P0102 Reinheit: 99.72%: Data Sheet
COA

SDS
Handling Instructions
FAQs
Technical Support

Dipeptide diaminobutyroyl benzylamide diacetate, a Wagerlin-1-mimicking peptide, is a nAChR antagonist. Dipeptide diaminobutyroyl benzylamide diacetate mimics Waglerin-1 to block neuromuscular junction nicotinic acetylcholine receptors, partially inhibits neuronal signal transduction, and relaxes muscles. Dipeptide diaminobutyroyl benzylamide diacetate reduces appearance of facial wrinkles linked to repeated muscle movement.Dipeptide diaminobutyroyl benzylamide diacetate can be used for the research of mild-to-moderate fine and coarse periocular and perioral wrinkles and periorbital ageing.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

Kundenspezifische Peptidsynthese

Dipeptide diaminobutyroyl benzylamide diacetate Chemische Struktur

CAS. Nr. : 823202-99-9

Größe	Verfügbarkeit	Menge
50 mg	Auf Lager	Estimated Time of Arrival: December 31
100 mg	Auf Lager	Estimated Time of Arrival: December 31
250 mg	Auf Lager	Estimated Time of Arrival: December 31
500 mg	Angebot einholen
1 g	Angebot einholen

or Massenanfrage

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

This product is a controlled substance and not for sale in your territory.

Kundenbewertung

Based on 1 Customer Validation

Spezialitätsempfehlungen

•Related Screening Libraries:

•Related Small Molecules:

•Related Proteins:

Biologische Aktivität
Reinheit & Dokumentation
Verweise
Kundenbewertung

Beschreibung

In Vitro

Dipeptide diaminobutyroyl benzylamide diacetate is an anti-wrinkle polypeptide that can be used in cosmetic research^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Molekulargewicht

495.57

Formel

C₂₃H₃₇N₅O₇

CAS. Nr.

823202-99-9

Appearance

Solid

Color

White to off-white

Sequence

{beta-Ala}-Pro-{Dab-NHBzl}

Sequence Shortening

{beta-Ala}-P-{Dab-NHBzl}

Versand

Room temperature in continental US; may vary elsewhere.

Speicherung

Sealed storage, away from moisture

Powder	-80°C	2 years
	-20°C	1 year

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

Lösungsmittel & Löslichkeit

In Vitro:

DMSO : 100 mg/mL (201.79 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Preparing
Stock Solutions

Concentration Solvent Mass	1 mg	5 mg	10 mg

1 mM	2.0179 mL	10.0894 mL	20.1788 mL
5 mM	0.4036 mL	2.0179 mL	4.0358 mL
10 mM	0.2018 mL	1.0089 mL	2.0179 mL

View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Molaritätsrechner
Verdünnungsrechner

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

This equation is commonly abbreviated as: C₁V₁ = C₂V₂

Concentration _(start)

Volume _(start)

Concentration _(final)

Volume _(final)

In Vivo Dissolution Calculator

Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Calculation results:

Working solution concentration: mg/mL

Reinheit & Dokumentation

Purity: 99.72%

Select Batch:

Data Sheet (279 KB) SDS (393 KB)

COA (257 KB) RP-HPLC (112 KB) MS (231 KB) Elemental Analysis Report (115 KB)

Handling Instructions (2659 KB)

Verweise

[1]. Trookman NS, et al. Immediate and Long-term Clinical Benefits of a Topical Treatment for Facial Lines and Wrinkles. J Clin Aesthet Dermatol. 2009;2(3):38-43. [Content Brief]

[2]. D'Arcangelis A, et al. In vitro, ex vivo, instrumental and clinical evaluation of a topical cream on the signs of periorbital ageing. Int J Cosmet Sci. 2025;47(1):18-30. [Content Brief]

Complete Stock Solution Preparation Table

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg

DMSO	1 mM	2.0179 mL	10.0894 mL	20.1788 mL	50.4470 mL
	5 mM	0.4036 mL	2.0179 mL	4.0358 mL	10.0894 mL
	10 mM	0.2018 mL	1.0089 mL	2.0179 mL	5.0447 mL
	15 mM	0.1345 mL	0.6726 mL	1.3453 mL	3.3631 mL
	20 mM	0.1009 mL	0.5045 mL	1.0089 mL	2.5223 mL
	25 mM	0.0807 mL	0.4036 mL	0.8072 mL	2.0179 mL
	30 mM	0.0673 mL	0.3363 mL	0.6726 mL	1.6816 mL
	40 mM	0.0504 mL	0.2522 mL	0.5045 mL	1.2612 mL
	50 mM	0.0404 mL	0.2018 mL	0.4036 mL	1.0089 mL
	60 mM	0.0336 mL	0.1682 mL	0.3363 mL	0.8408 mL
	80 mM	0.0252 mL	0.1261 mL	0.2522 mL	0.6306 mL
	100 mM	0.0202 mL	0.1009 mL	0.2018 mL	0.5045 mL